NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-072-2001-0-US-05 Identification of New Small RNAs and ORFs Of E. Coli As Mediators Of Cell And Intercell Regulation US DIV 12/905,288 Abandoned
CC E-029-2011-0-US-01 FEEDBACK CONTROL FOR MILD HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE GUIDED FOCUSED ULTRASOUND US 61/393,469 Abandoned
NCI E-270-2010-0-US-01 Mutations In Metastatic Prostate Cancer US 61/393,757 Abandoned
NINDS E-144-2008-0-US-04 Movement Correction In MRI Using A Camera US National Stage 12/937,852 9545217 Abandoned PDF
NINDS E-081-2008-2-US-05 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US National Stage 12/937,843 9084820 Issued PDF
NIA E-051-2008-0-JP-06 Compositions and Methods for Delivering Inhibitory Oligonucleotides JP National Stage 2011-505154 Abandoned
NHLBI E-138-2008-0-US-03 Peptides Promoting Lipid Efflux US National Stage 12/937,974 8936787 Issued PDF
NIMH E-274-2015-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING BLADDER CANCER PCT PCT PCT/US2010/52634 Expired
NCI E-174-2008-0-JP-07 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma JP National Stage 2011-505173 Abandoned
NIAID E-197-2010-0-US-01 Compositions And Methods For Controlling Neurotropic Viral Pathogenesis By MicroRNA Targetting US 61/455,261 Abandoned
NCI E-174-2008-0-US-03 Silencing Of CSN5 Gene Expression Using Interfering RNA US National Stage 12/903,558 8227443 Issued PDF
NIAID E-010-2011-0-PCT-02 Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. PCT PCT PCT/US2010/52484 Expired
NCI E-077-2008-0-US-03 Methods and Compositions For the Delivery of Vaccines to Disrupted Epithelium US National Stage 12/863,572 Abandoned
NCATS E-211-2010-0-US-01 Compounds And Methods For The Treatment Of Giardiasis US 61/392,096 Abandoned
NCI E-158-2009-0-CA-04 Granulysin In Immunotherapy CA National Stage 2777400 Abandoned
NCI E-158-2009-0-EP-05 Granulysin In Immunotherapy EP National Stage 10823873.4 Abandoned
NCI E-158-2009-0-AU-03 Granulysin In Immunotherapy AU National Stage 2010307075 Abandoned
NIAID E-142-2008-0-US-03 Humanized Monoclonal Antibodies That Specifically Bind And/Or Neutralize Japanese Encephalitis Virus (JEV) And Their Use US National Stage 12/937,227 8506961 Abandoned PDF
NCI E-158-2009-0-PCT-02 Granulysin In Immunotherapy PCT PCT PCT/US2010/052036 Expired
NIDDK E-173-2008-0-US-03 MDCK Cells With Human Siat7e Gene Inserts Exhibit Capability Of Anchorage-independent Growth US National Stage 12/937,185 Abandoned
NCI E-340-2004-2-CA-03 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival CA National Stage 2590401 Expired
NCI E-232-2009-0-AU-03 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System AU National Stage 2010303383 Abandoned
NCI E-232-2009-0-PCT-02 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF)System PCT PCT PCT/US2010/051784 Expired
NCI E-232-2009-0-EP-05 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System EP National Stage 10822676.2 Abandoned
NCI E-232-2009-0-CA-04 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System CA National Stage 2774953 Abandoned
NIA E-081-2007-0-US-03 Cancer Chemoprevention Strategy Based On Loss Of Imprinting Of IGF2 US National Stage 12/446,735 Abandoned
NIAID E-006-2010-1-PCT-01 Mechanisms For Protection Against Pandemic Strains Of Influenza PCT PCT COMB PCT/US2010/051512 Expired
NIDCR E-009-2011-0-PCT-01 Treatment Of The Sjogren's Syndrome PCT PCT PCT/NL2010/050650 Expired
NCI E-172-2010-0-US-01 Potent Cross-reactive HIV-1-neutralizing Human Monoclonal Antibodies Targeting The Gp4I MPER US 61/248,796 Abandoned
NIAID E-031-2006-0-US-03 Chlamydia Vaccine US National Stage 12/087,952 9259463 Issued PDF
NCATS E-230-2009-0-PCT-02 Quinazolin-4-amine Derivatives and Methods of Use PCT PCT PCT/US2010/051090 Expired
NCI E-275-2005-1-US-06 Novel Molecular Scaffolds Are Broad-Spectrum Antibiotics US DIV 12/896,338 Abandoned
NCI E-297-2010-0-US-01 Compositions And Methods For Treating Neoplasia US 61/388,983 Abandoned
NCI E-239-2010-0-US-01 Manipulation Of Stem Cell Functions By P53 Isoforms2 US 61/389,134 Abandoned
NIDDK E-068-2010-2-US-01 Hepatitis C Virus Culture System US ORD 12/895,518 Abandoned
NCATS E-258-2010-0-US-01 Compounds, Pharmaceutical Compositions, And Methods of Treating Or Preventing Neurodegenerative Diseases Or Disorders US 61/388,482 Abandoned
NCATS E-259-2010-0-US-01 Compounds, Pharmaceutical Compositions, And Methods For Treating Or Preventing Lysosomal Storage Diseases US 61/388,434 Abandoned
NINDS E-144-2010-0-US-01 Therapeutic Approach To Neurodegenerative Disorders Using A TFP5-peptide US 61/387,839 Abandoned
NCI E-093-1996-3-GB-26 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES GB EP 10010885.1 Expired
NCI E-093-1996-3-FR-25 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES FR EP 10010885.1 Expired
NCI E-093-1996-3-DE-24 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES DE EP 10010885.1 Expired
NCI E-085-2003-2-JP-11 Cyanovirin Variant-Polymer Conjugates JP DIV 2010-216141 Expired
NIAID E-290-2010-0-US-01 Monoclonal Antibodies And Their Use US 61/386,948 Abandoned
NIAID E-046-2010-1-US-01 Simian Adenoviral Vector-based Vaccines US 61/386,994 Abandoned
NIAID E-291-2010-0-US-01 HIV Immunogens US 61/386,893 Abandoned
NIAID E-300-2009-5-IN-06 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE IN National Stage 588/KOLNP/2012 Issued
NIAID E-300-2009-5-IT-18 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use IT EP 10760878.8 Issued
NIAID E-300-2009-5-IE-17 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use IE EP 10760878.8 Issued
NIAID E-300-2009-5-BE-12 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use BE EP 10760878.8 Issued
NIAID E-300-2009-5-FR-15 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use FR EP 10760878.8 Issued